Previous New Releases from NCBI BookshelfBrigatinib for ALK-positive advanced non-small-cell lung cancer that has not been previously treated with an ALK inhibitor.Brigatinib for ALK-positive advanced non-small-cell lung cancer that has not been previously treated with an ALK inhibitor.